| The antigenic anatomy of SARS-CoV-2 receptor binding domain W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ... Cell 184 (8), 2183-2200. e22, 2021 | 356 | 2021 |
| Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 CP Thompson, NE Grayson, RS Paton, JS Bolton, J Lourenço, ... Eurosurveillance 25 (42), 2000685, 2020 | 130* | 2020 |
| Convalescent plasma therapy for the treatment of patients with COVID‐19: assessment of methods available for antibody detection and their correlation with neutralising antibody … H Harvala, ML Robb, N Watkins, S Ijaz, S Dicks, M Patel, P Supasa, ... Transfusion Medicine 31 (3), 167-175, 2021 | 102 | 2021 |
| Rubisco adaptation is more limited by phylogenetic constraint than by catalytic trade-off JW Bouvier, DM Emms, T Rhodes, JS Bolton, A Brasnett, A Eddershaw, ... Molecular Biology and Evolution 38 (7), 2880-2896, 2021 | 39 | 2021 |
| Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses AL McNaughton, RS Paton, M Edmans, J Youngs, J Wellens, P Phalora, ... JCI insight 7 (13), 2022 | 32 | 2022 |
| SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020 SF Lumley, DW Eyre, AL McNaughton, A Howarth, S Hoosdally, SB Hatch, ... Eurosurveillance 25 (42), 2001721, 2020 | 22 | 2020 |
| A globally ubiquitous symbiont can drive experimental host evolution KA Bates, JS Bolton, KC King Molecular Ecology 30 (15), 3882-3892, 2021 | 8 | 2021 |
| An antigenic thrift-based approach to influenza vaccine design JS Bolton, H Klim, J Wellens, M Edmans, U Obolski, CP Thompson Vaccines 9 (6), 657, 2021 | 5 | 2021 |
